Adagio Medical Holdings Overview
Valuation check: ADGM's ROE is -425.61%, below the sector sector average of -5.87%.
Get informed when a big investor buys or sells
+ Follow-425.61%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Adagio Medical Holdings (ADGM) currently reports a ROE of -425.61%. That is below the sector sector average of -5.87%. Use the charts on this page to explore Adagio Medical Holdings's ROE history and peer comparisons.
Adagio Medical Holdings's ROE of -425.61% is lower than the its sector sector average of -5.87%. That is roughly 7152.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Adagio Medical Holdings's current -425.61% should be judged against industry norms (sector average: -5.87%) and against ADGM's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -425.61%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.87%. From there, open related valuation or income-statement pages for Adagio Medical Holdings, and consider following ADGM for alerts when major investors trade the stock.
